danvatirsen   Click here for help

GtoPdb Ligand ID: 13607

Synonyms: AZD-9150 | AZD9150 | ISIS STAT3Rx
Compound class: Nucleic acid
Comment: Danvatirsen (AZD9150) is a phosphorothioate antisense oligonucleotide that was designed to inhibit expression of signal transducer and activator of transcription 3 (STAT3) as an anti-tumour mechanism [2-4]. It contains 2′-4′ constrained ethyl (cEt)-modified residues that increase affinity for target mRNA [2].

Full sequence as provided in the agent's INN record is: all-P-ambo-2'-O,4'-C-[(1S)-ethane-1,1-diyl]-5-methyl-P-thiocytidylyl-(3'→5')-2'-O,4'-C-[(1S)-ethane-1,1-diyl]-5-methyl-P-thiouridylyl-(3'→5')-2'-O,4'-C-[(1S)-ethane-1,1-diyl]-P-thioadenylyl-(3'→5')-P-thiothymidylyl-(3'→5')-P-thiothymidylyl-(3'→5')-P-thiothymidylyl-(3'→5')-2'-deoxy-P-thioguanylyl-(3'→5')-2'-deoxy-P-thioguanylyl-(3'→5')-2'-deoxy-P-thioadenylyl-(3'→5')-P-thiothymidylyl-(3'→5')-2'-deoxy-P-thioguanylyl-(3'→5')-P-thiothymidylyl-(3'→5')-2'-deoxy-5-methyl-P-thiocytidylyl-(3'→5')-2'-O,4'-C-[(1S)-ethane-1,1-diyl]-P-thioadenylyl-(3'→5')-2'-O,4'-C-[(1S)-ethane-1,1-diyl]-P-thioguanylyl-(3'→5')-2'-O,4'-C-[(1S)-ethane-1,1-diyl]-5-methylcytidine, but we have been unable to resolve this to a SMILES or HELM notation.
References
1. Besse B, Pons-Tostivint E, Park K, Hartl S, Forde PM, Hochmair MJ, Awad MM, Thomas M, Goss G, Wheatley-Price P et al.. (2024)
Biomarker-directed targeted therapy plus durvalumab in advanced non-small-cell lung cancer: a phase 2 umbrella trial.
Nat Med, 30 (3): 716-729. [PMID:38351187]
2. Hong D, Kurzrock R, Kim Y, Woessner R, Younes A, Nemunaitis J, Fowler N, Zhou T, Schmidt J, Jo M et al.. (2015)
AZD9150, a next-generation antisense oligonucleotide inhibitor of STAT3 with early evidence of clinical activity in lymphoma and lung cancer.
Sci Transl Med, 7 (314): 314ra185. [PMID:26582900]
3. Lau YK, Ramaiyer M, Johnson DE, Grandis JR. (2019)
Targeting STAT3 in Cancer with Nucleotide Therapeutics.
Cancers (Basel), 11 (11). [PMID:31671769]
4. Shiah JV, Grandis JR, Johnson DE. (2021)
Targeting STAT3 with Proteolysis Targeting Chimeras and Next-Generation Antisense Oligonucleotides.
Mol Cancer Ther, 20 (2): 219-228. [PMID:33203730]